Minority AIDS Initiative Retention and Re-Engagement Project
NCT ID: NCT01616940
Last Updated: 2017-03-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
348 participants
INTERVENTIONAL
2011-09-30
2014-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Peer-Driven Intervention to Enroll Minorities/Women in HIV/AIDS Clinical Trials (the ACT2 Project)
NCT00593983
Enhanced Access to HIV Care for Drug Users in San Juan, Puerto Rico
NCT01792752
Intervention to Improve HIV Care Retention by Addressing Stigma Stigmatized Environments
NCT05110963
Leveraging mHealth and Peers to Engage African- Americans and Latinxs in HIV Care (LEAN)
NCT03934437
Peer Mentors for Adolescents in HIV Affected Families
NCT00056953
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Study participants will be current or newly enrolled patients of three clinics: CARE Resources, in Miami FL, the PATH Program at Brooklyn Hospital in Brooklyn, NY, and PR CONCRA located in San Juan Puerto Rico who (1) have been out of care for 4 months or more or (2) present a need for substance abuse, mental health, or housing services.
Data will be collected at baseline and follow up (at six and twelve months) through client questionnaires, selected medical chart data (visit dates, laboratory tests and values) and intervention encounter forms on approximately 375 HIV positive adults. The data collected for this study will allow us to assess changes in: (a) retention in HIV primary care, (b) viral load suppression, (c) health-related quality of life, (d) self-efficacy, and (e) HIV knowledge that may be associated with an enhanced peer intervention.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard-of-care
Standard-of-care at 3 demonstration sites includes: HIV medical care, medical case management, and referral to substance abuse, mental health, and housing services.
No interventions assigned to this group
Enhanced Peer Intervention
Provides emotional, informational, and instrumental peer support, in addition to Standard-of-Care.
Enhanced Peer Intervention
Eight 30-60 minute educational sessions with peer will occur in-person bi-weekly once participant is randomized to intervention:
* Introduction and Assessment
* HIV Transmission \& Viral Life Cycle
* Effective Communication and Self-Advocacy
* Understanding Lab Values
* HIV Medications
* Drug Resistance \& Adherence, and Understanding \& Managing Side Effects
* Disclosure and Stigma
* Harm \& Risk Reduction
Weekly check-ins will be by phone or in-person over 12 months. Check-in questions/tasks:
* Are any services needed?
* Have referrals or appointments been made?
* Does patient need accompaniment to a visit?
* Connect patient with services as needed.
* Appointment reminders.
* Overall well-being?
* Schedule next peer contact.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Enhanced Peer Intervention
Eight 30-60 minute educational sessions with peer will occur in-person bi-weekly once participant is randomized to intervention:
* Introduction and Assessment
* HIV Transmission \& Viral Life Cycle
* Effective Communication and Self-Advocacy
* Understanding Lab Values
* HIV Medications
* Drug Resistance \& Adherence, and Understanding \& Managing Side Effects
* Disclosure and Stigma
* Harm \& Risk Reduction
Weekly check-ins will be by phone or in-person over 12 months. Check-in questions/tasks:
* Are any services needed?
* Have referrals or appointments been made?
* Does patient need accompaniment to a visit?
* Connect patient with services as needed.
* Appointment reminders.
* Overall well-being?
* Schedule next peer contact.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18 years or older; AND
* Identifies as belonging to one or more of the following racial/ethnic groups: American Indian or Alaskan Native, Asian, Black or African-American, Hispanic or Latino, native Hawaiian or other Pacific Islander; AND
* New patient to clinic (including newly-diagnosed) whose initial assessment or intake form indicates a need for substance abuse treatment, mental health or housing services, or a past history of substance abuse or mental health services; OR
* The individual has been out of medical care at your clinic for 4 months or more.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Care Resource
UNKNOWN
The Brooklyn Hospital Center
OTHER
Puerto Rico Community Network for Clinical Research on AIDS
OTHER
Justice Resource Institute
OTHER
Kansas City Free Health Clinic
UNKNOWN
Boston University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jane Fox, MPH
Role: PRINCIPAL_INVESTIGATOR
Center for Advancing Health Policy and Practice, Boston University School of Public Health
Serena Rajabiun, MA, MPH
Role: PRINCIPAL_INVESTIGATOR
Center for Advancing Health Policy and Practice, Boston University School of Public Health
Howard Cabral, MPH, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Biostatistics, Boston University School of Public Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Care Resource
Miami, Florida, United States
Center for Advancing Health Policy and Practice
Boston, Massachusetts, United States
PATH Center, The Brooklyn Hospital
Brooklyn, New York, United States
Puerto Rico Community Network for Clinical Research on AIDS
San Juan, , Puerto Rico
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Cabral HJ, Davis-Plourde K, Sarango M, Fox J, Palmisano J, Rajabiun S. Peer Support and the HIV Continuum of Care: Results from a Multi-Site Randomized Clinical Trial in Three Urban Clinics in the United States. AIDS Behav. 2018 Aug;22(8):2627-2639. doi: 10.1007/s10461-017-1999-8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
U69HA23262
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.